Showing results (41-50 of 406) with videos related to
Sort By:
Pageof 41
Breast Disease|June 1, 2006
Clinical aspects of inflammatory breast cancerJanice M Walshe, Sandra M SwainCancer Journal (Sudbury, Mass.)|December 9, 2008
Therapeutic strategies for triple-negative breast cancerAntoinette R Tan, Sandra M SwainJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
Peripheral neuropathy induced by microtubule-stabilizing agentsJames J Lee, Sandra M SwainClinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2016
Molecular Pathways: AXL, a Membrane Receptor Mediator of Resistance to TherapyMaurizio Scaltriti, Moshe Elkabets, José BaselgaSeminars in Oncology|October 19, 2004
Molecular approach to breast cancer treatmentYosef Yarden, José Baselga, David MilesNature Reviews. Clinical Oncology|March 6, 2013
Emerging targeted agents in metastatic breast cancerDimitrios Zardavas, José Baselga, Martine PiccartNature Reviews. Drug Discovery|November 7, 2022
Targeting HER2-positive breast cancer: advances and future directionsSandra M Swain, Mythili Shastry, Erika HamiltonThe New England Journal of Medicine|February 19, 2015
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancerSandra M Swain, José Baselga, Sung-Bae Kim, et al.The Lancet. Oncology|April 23, 2013
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 studySandra M Swain, Sung-Bae Kim, Javier Cortés, et al.Pageof 41